Literature DB >> 11207792

Reexamination of interictal psychoses based on DSM IV psychosis classification and international epilepsy classification.

K Kanemoto1, T Tsuji, J Kawasaki.   

Abstract

We sought to examine interictal psychoses based on the international epilepsy classification and DSM IV criteria, with special attention paid to epilepsy types as well as to subcategories of psychoses. One hundred thirty-two outpatients were studied, each with definite evidence of both epilepsy and interictal psychosis clearly demarcated from postictal psychosis. We compared them with 2,773 other epilepsy outpatients as a control. Risk factors for psychosis were examined within the temporal lobe epilepsy (TLE) group and the more extended group of symptomatic localization-related epilepsy. Further, nuclear schizophrenia and other nonschizophrenic psychotic disorders were compared. We confirmed a close correlation between TLE and interictal psychoses. Within the TLE group, only early epilepsy onset and a history of prolonged febrile convulsions were revealed to be significantly associated with interictal psychosis. Within the symptomatic localization-related epilepsy group, such parameters as complex partial seizures, autonomic aura, and temporal EEG foci were closely associated with psychoses. There was also a significant difference between groups as to ictal fear and secondary generalization. Whereas patients with early psychosis onset and a low intelligence quotient were overrepresented in the nuclear schizophrenia group, drug-induced psychosis and alternative psychosis were underrepresented. TLE proved to be preferentially associated with interictal psychoses. Within the TLE group, medial TLE in particular was found to be more closely associated with psychosis. Our data support the original postulation of Landolt, stating that alternative or drug-induced psychoses constitute a definite subgroup of interictal psychoses, which are different from chronic epileptic psychoses that simulate schizophrenia.

Entities:  

Mesh:

Year:  2001        PMID: 11207792     DOI: 10.1046/j.1528-1157.2001.09000.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  9 in total

1.  A young woman with seizures and psychosis.

Authors:  Sowjanya Naha; Kushal Naha; H Manjunath Hande; Ganapathiraman Vivek
Journal:  BMJ Case Rep       Date:  2014-07-09

Review 2.  Alternating and postictal psychoses: review and a unifying hypothesis.

Authors:  Perminder S Sachdev
Journal:  Schizophr Bull       Date:  2007-03-03       Impact factor: 9.306

3.  Psychotic Disorders in Epilepsy: Do They Differ from Primary Psychosis?

Authors:  Kousuke Kanemoto
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 4.  Schizophrenia and epilepsy: is there a shared susceptibility?

Authors:  Nicola G Cascella; David J Schretlen; Akira Sawa
Journal:  Neurosci Res       Date:  2009-04       Impact factor: 3.304

5.  Psychotic illness in patients with epilepsy.

Authors:  Kousuke Kanemoto; Yukari Tadokoro; Tomohiro Oshima
Journal:  Ther Adv Neurol Disord       Date:  2012-11       Impact factor: 6.570

6.  Dysfunctional GABAergic inhibition in the prefrontal cortex leading to "psychotic" hyperactivation.

Authors:  Shoji Tanaka
Journal:  BMC Neurosci       Date:  2008-04-25       Impact factor: 3.288

7.  A patient with epileptic psychosis who had rare acute episodic symptoms.

Authors:  Toru Horinouchi; Yuka Oyanagi; Yuka Umemoto; Yoshiyuki Hosokawa; Hiroshi Honma; Shigehiro Matsubara
Journal:  Epilepsy Behav Case Rep       Date:  2014-08-19

8.  Antiepileptic drug-induced psychosis associated with MTHFR C677T: a case report.

Authors:  Masaru Shimura; Hikari Yamada; Hidekuni Takahashi; Naoto Yamada; Soken Go; Gaku Yamanaka; Hisashi Kawashima
Journal:  J Med Case Rep       Date:  2019-08-12

9.  Individual vulnerabilities to psychosis after antiepileptic drug administration.

Authors:  Nozomi Akanuma; Naoto Adachi; Peter Fenwick; Masumi Ito; Mitsutoshi Okazaki; Koichiro Hara; Ryouhei Ishii; Masanori Sekimoto; Masaaki Kato; Teiichi Onuma
Journal:  BMJ Neurol Open       Date:  2020-08-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.